Compare CVBF & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CVBF | PBH |
|---|---|---|
| Founded | 1974 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | N/A | 2005 |
| Metric | CVBF | PBH |
|---|---|---|
| Price | $19.88 | $65.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $23.88 | ★ $86.40 |
| AVG Volume (30 Days) | ★ 1.3M | 337.3K |
| Earning Date | 01-21-2026 | 02-05-2026 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | ★ 5.58 | N/A |
| EPS | 1.52 | ★ 4.04 |
| Revenue | $518,957,999.00 | ★ $1,110,479,000.00 |
| Revenue This Year | $22.66 | N/A |
| Revenue Next Year | $15.56 | $2.50 |
| P/E Ratio | ★ $13.05 | $16.28 |
| Revenue Growth | ★ 2.80 | N/A |
| 52 Week Low | $16.01 | $57.25 |
| 52 Week High | $21.41 | $90.04 |
| Indicator | CVBF | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 53.71 | 59.18 |
| Support Level | $19.63 | $63.97 |
| Resistance Level | $21.13 | $68.28 |
| Average True Range (ATR) | 0.53 | 1.83 |
| MACD | 0.13 | 0.22 |
| Stochastic Oscillator | 51.81 | 65.86 |
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.